SUMMARY Four studies are included in this report on the relationship of blood pressure, protein excretion, and renal hemodynamics, where renal function was measured by 1Z5 I-iothalamate clearance and l3l I-hippuran clearance, and urinary albumin excretion was measured by radioimmunoassay. The first concerns the relationship between blood pressure and renal function in a cross-sectional study of 56 patients with type I diabetes with various degrees of renal involvement. In the second, multiple regression analysis was used in a prospective study of diabetic nephropathy in patients with type I diabetes. Inclusion criteria were age at diagnosis less than 20 years, initial diabetes duration 3 to 20 years, and follow-up period more than 7 years. Urinary albumin was less than 70 ^g/min, and glomerular filtration rate, renal plasma flow, and urinary albumin were measured in all patients. The third was a long-term follow-up study of persons with type I diabetes, with special reference to development of changes in urinary albumin, glomerular filtration rate, and blood pressure. Diabetes duration in this study was 7 to 20 years. Finally, a prospective study was conducted on clinical proteinuria and mortality in patients with type II diabetes, with special reference to initial urinary albumin and blood pressure. A close association was established among all variables measured in the cross-sectional study. On multiple regression analysis as well as in the long-term follow-up study, it appeared that both elevated urinary albumin (> 15 /xglmin at baseline) and high glomerular filtration rate (> 150 ml/min) are major determinants for subsequent progression to nephropathy. In patients with type II disease, increase in urinary albumin is a strong predictor for development of proteinuria and early mortality. High blood pressure seems not to be a major determinant in these patients, but further studies are required. ( are only a few reports, however, on the relationship between renal function values and blood pressure level. Also, it is not clear (1) how early in the development of nephropathy blood pressure starts to increase or (2) whether an early increase has any predictive power with respect to future development of renal disease.
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The aim of the present study was to clarify the relationship between elevated blood pressure and renal function changes in a large diabetic population with various degrees of renal involvement. In addition, the predictive value of increased blood pressure was compared to that of other possible risk factors such as blood glucose level, urinary albumin excretion, and glomerular filtration rate (GFR). The development of blood pressure changes in comparison to changes in urinary albumin and glomerular filtration rate was also investigated in long-term follow-up studies in patients with types I and II diabetes.
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Patients and Methods Definition of Stages in Renal Involvement in Diabetes
The following classification was used when subdividing patients with type I diabetes 8 according to urinary albumin excretion (UAE):
Stage I: early changes found at the clinical diagnosis of diabetes, related to poor metabolic control Stage D: rate of UAE within normal limits irrespective of duration of diabetes (with lesions but without clinical signs of renal disease) Stage III: incipient diabetic nephropathy characterized by persisting elevation of UAE despite standard metabolic control, in patients without clinical proteinuria (UAE > 15 tig/min but total protein excretion < 0.5 g/24 hr) Stage IV: overt diabetic nephropathy characterized by clinical proteinuria measured by a standard test, for example, sulphosalicylic acid method Stage V: end-stage renal failure characterized by uremia
Methods
Urinary albumin excretion rate (expressed as pig/ min) was measured by radioimmunoassay, 9 in most cases using short-term collections during measurements of GFR and renal plasma flow (RPF). Both GFR and RPF were measured by constant infusion technique with four to six urine collections using 125 I-iothalamate and l3l I-hippuran as markers. 10 In a few cases, inulin and para-aminohippuric acid (PAH) were used as markers. Blood pressure was measured by standard mercury manometer, cuff width 12 cm, after the patient had rested for at least 20 minutes in the supine position. Diastolic pressure was recorded as phase 5.
In patients with type II diabetes, urinary albumin was measured in morning urine samples in the outpatient clinic, and concentrations (UAC) expressed as micrograms per milliliter. Blood pressure recordings were taken from the case reports. The above procedure was also used in blood pressure determinations in the clinic.
Studies
The following four studies are included in this report. Study A: relationship between blood pressure and renal function values in patients with type I diabetes Study B: multiple regression analysis used in the prediction of diabetic nephropathy in type I diabetes (with special reference to UAE, GFR, and blood pressure level) Study C: long-term (mean 10 years) follow-up in persons with type I diabetes, with special reference to changes in UAE, GFR, and blood pressure Study D: prediction of clinical proteinuria and mortality in patients with type II diabetes, with special reference to initial UAC and blood pressure
The criteria for entering these studies were as follows.
Study A: all male insulin-dependent patients age less than 40 years and with age at diagnosis of diabetes less than 30 years, who had renal function test performed together with measurement of UAE and blood pressure.
Study B: age at diagnosis of diabetes less than 20 years, initial diabetes duration 3 to 20 years and follow-up more than 7 years, and UAE less than 70 ^tg/rnin at entry. In addition GFR, RPF, and UAE had to be measured initially (and at follow-up). Thirty-one patients fulfilled these criteria and all patients agreed to the reexamination, which took place a mean of 11.5 years after the initial examination. Two patients with diabetes duration of 3 years were excluded since their high UAE rapidly normalized. Study C: age at diagnosis less than 20 years, diabetes duration 7 to 20 years and foliow-up more than 7 years, and UAE less than 70 /xg/min at entry. Also, GFR and RPF (at entry and follow-up) were measured in 24 and 28 patients respectively. Determination of GFR was done without any specific selection. Forty-one patients fulfilled these criteria, 40 agreed to reexamination in mean 10.4 years ± 3 (SD) later. 
Statistical Analysis
We used standard paramedical statistics. Logarithmic transformation was used in calculating results of albumin excretion rate. In study B, multiple regression analysis was used according to the system of the Statistical Package for the Social Sciences." Table 1 shows data on renal function tests and blood pressure measurements as well as plasma glucose taken at examination. Patients with newly diagnosed diabetes are included so comparison can be made, but data on them do not appear in subsequent figures. In stage II, a slight but significant increase was found in blood pressure level as well as in filtration fraction and renal vascular resistance. The GFR was increased, whereas RPF was at the normal level. In stage III, albumin excretion was elevated by definition. Blood pressure level was significantly increased in comparison with stage II and controls. Also, renal vascular resistance and filtration fraction were increased, but RPF was again within the normal range.
Results
Study A
In stage IV, blood pressure was considerably increased, and expectedly, both GFR and RPF were considerably decreased and UAE was high.
Figures 1,2, and 3 show correlations between blood pressure level and renal function values. A very close positive correlation was found between UAE and mean blood pressure. The three stages shown on the graphs seem to represent a continuum. The same is the case with respect to the negative correlation between GFR and mean blood pressure as well as between RPF and mean blood pressure. The highest correlation was be- The results are given in mean ± SD except for albumin excretion, which is given in geometric mean X/-H tolerance factor because of calculations after being log-transformed.
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FIGURE 3. Renal plasma flow plotted against mean blood pressure (patient signs as in Figures 1 and 2; in three patients RPF was not measured).
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UEMt BLOOO PRESSURE rm+HQ tween albumin excretion rate and blood pressure (r = 0.81) and degree of correlation was less with respect to GFR (r = -0 . 6 3 ) and RPF (r = -0 . 5 1 ) .
Study B Clinical data relevant to study B and results from renal function tests, both initially and at follow-up, are shown in Table 2 . A multiple regression analysis was performed with follow-up UAE as the dependent variable. The relative roles of values from the initial examination were tested, namely, age at diagnosis of diabetes, diabetes duration; systolic and diastolic, and mean blood pressures; plasma glucose at examination; UAE, GFR, and RPF. The resultsof this multivariance analysis are shown in Table 3 . Both UAE and GFR were the major determinants of follow-up UAE in this analysis.
With respect to fall rate of GFR, analysis was carried out with and without GFR from the initial examination. Including GFR, this value appeared to be a major determinant. Disregarding GFR in this analysis, UAE was the major determinant, without a contribution of any other variables (Tables 4 and 5 ).
Determinants of elevation in blood pressure, both initially and at follow-up, are shown in Tables 6 and 7. The initial level of GFR was a significant determinant for initial mean blood pressure. With respect to followup mean blood pressure, initial UAE was the major determinant (2p = 0.0027).
Study C
Progression to diabetic nephropathy was defined as development of clinical proteinuria or UAE higher than 150 /xg/min. Progression to diabetic nephropathy occurred in nine patients. In four patients, some increase in UAE at follow-up was found but not clinical proteinuria (UAE 5.9 /xg/min ± 2.9 (SD) to 41.1 ± 17.4). Data on these four patients are not shown in subsequent figures.
The UAEs in those who did and did not progress to diabetic nephropathy are shown in Figure 4 . The UAE increased in diabetic nephropathy or was greater than 150 fig/min only in patients with an initial value above 15 /ag/min (mean 25.6 /Ag/min). Only two patients with an excretion rate of more than 15 remained stable or declined (Figure 4) . Mean values for nonprogressors were 6.5 and 5.4 (initially and at follow-up). Figure 5 shows data on GFR measurements in the same group. The GFR was measured initially and at follow-up in only 6 patients who progressed and in 12 Table 3 for abbreviations). Table 3 for abbreviations). *Initial GFR excluded. Table 3 for abbreviations). Table 3 for abbreviations). who did not. A marked decline occurred in progressors, whereas patients with stable UAE also remained stable with respect to GFR. High GFR was found in all patients initially, when it was calculated from serum creatinine. 12 Mean blood pressure increased in progressors but remained stable in nonprogressors with only a slight tendency to increase ( Figure 6 ). Table 8 shows clinical data on patients with type II diabetes at the original examination in 1973 and data on survival at follow-up. There was close correlation between the initial level of UAC and subsequent survival. In addition, initial blood pressure was completely identical in the four groups with different albumin concentrations but who were otherwise similar with respect to age, diabetes duration, age at diagnosis, and treatment modality. Fasting plasma glucose values also were identical initially. A number of patients received antihypertensive treatment. No correlation between blood pressure and UAC could be established at follow-up.
Study D
Discussion
This study documented the close association between blood pressure elevation and involvement of renal function in insulin-dependent diabetic patients. Only a very slight elevation of blood pressure was found in those with normal UAE and values were within the normal range. On the other hand, in the phase of incipient diabetic nephropathy, there was a clear elevation of blood pressure, although only a few patients reached the definitive hypertensive level. In overt diabetic nephropathy, blood pressure was decidedly elevated, as shown in other studies.
1 " 3 The association between blood pressure elevation and renal function is documented in Figures 1 to 3 . The best association is with UAE. The GFR may be in the normal range in patients with low UAE and in the early phase of overt nephropathy, 13 and it is therefore not surprising that a lesser degree of correlation was found here. In non-insulin-dependent patients the association was less certain. No firm elevation of blood pressure was found in a survey study of such patients with microalbuminuria (see Table 8 ). Increased albumin excretion may have been caused by a number of other abnormalities in these patients, 14 and blood pressure elevation may have been due to increased body weight or to essential hypertension, both abnormalities probably more common in non-insulin-dependent than in insulin-dependent diabetics.
Increased blood pressure is an early marker for incipient diabetic nephropathy; however, its predictive power is much less pronounced than that of increased UAE and GFR. Increases in those values are the predominant factors with respect to subsequent overt diabetic nephropathy, when analyzed both according to final UAE and fall rate in GFR. In the multivariance study reported here, UAE was the most important determinant with respect to late elevation of blood pressure (see Tables 6 and 7 ). 
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The observation that marginal elevation of UAE and early blood pressure changes are associated might prove extremely important to therapy. Indeed, two studies 4 -5 have shown that antihypertensive treatment is able to reduce progression of diabetic nephropathy in its overt phase. A recent study 15 carried out on a limited number of patients showed that antihypertensive treatment, also in the phase of incipient diabetic nephropathy and with still supranormal GFR, is able to reverse early abnormalities in UAE.
On the basis of these and other observations, 16 it is likely that a combination of metabolic and hemodynamic changes, characteristically found in diabetic patients during standard therapy, induces structural abnormalities in the kidneys, primarily in the glomeruli. When prominent, these changes in turn raise blood pressure. The concept that a slight elevation of blood pressure is an accelerating factor in the course of renal involvement in diabetes 17 is supported by the observation that both the degree of proteinuria and fall rate of GFR are at least partially reversible by antihypertensive treatment.
2 ' 4 -5 Of importance also is the rather close association found between morphological lesions and blood pressure elevation. 6 -7 -l8 This was documented by Gellmann et al. , 6 who found a close association between diffuse diabetic glomerulosclerosis and diastolic pressure. They noted that there was no correlation between nodular diabetic glomerulosclerosis and diastolic blood pressure. Kuhlmann and Mehnert, 7 however, found a close correlation between nodular glomerular lesions and hypertension. In the study by Mauer et al., 18 mesangial expansion was a clear finding in patients with high blood pressure. When mesangial volume exceeded more than 37% of glomerular volume, hypertension could be definitively predicted. Perhaps the increase in mesangial volume is reversible by effective antihypertensive treatment. Also, it has not been ruled out that maximized control of diabetes could reverse these abnormalities. No correlation between blood pressure level and basement membrane thickness could be established in this study.' 8 The level of microalbuminuria was associated with the number of occluded glomeruli, a clearly important finding. 18 In our follow-up study it appeared that even a slightly increased UAE, initial mean value of approximately 25 /xg/min (range 15-44 /tg/min), predicted overt diabetic nephropathy as seen in Figure 4 . On the other hand, patients with normal UAE were stable, although four progressed to microalbuminuria. A marked finding was the high GFR found initially in progressors, in contrast to the only moderate elevation in nonprogressors. At follow-up, GFR was clearly reduced in the former, suggesting that early hyperfiltration plays an important role in the pathogenesis of overt diabetic nephropathy. The underlying cause of hyperfiltration and increased UAE is not clearly established. It may be related to quality of long-term metabolic control, but it seems not to be a prominent finding since mean plasma glucose was no different in the two groups. Rather, it appears that some patients respond with glomerular hyperfiltration to average diabetes control whereas others do not. In the long run this phenomenon may well determine the final outcome in diabetic patients.
Early elevation of blood pressure was also a prominent finding, and blood pressure increased considerably more at follow-up in patients showing progression, suggesting that early elevation plays an important role in the pathogenesis of diabetic nephropathy. We also demonstrated that an increase rate in UAE (%/yr) in the phase of incipient diabetic nephropathy was closely associated to blood pressure level. 17 Viberti et al. 19 and Feldt-Rasmussen 20 also noted elevated blood pressure in similar patients.
In patients with type II diabetes the association between increased UAE and increased blood pressure was less clear. Increase in UAE predicts early mortality in these patients, but it is still an open question to what degree blood pressure abnormalities are involved in this mortality. Close monitoring of blood pressure after the establishment of microalbuminuria may disclose definitive blood pressure changes in these patients, but such a follow-up study remains to be carried out. Increase in mortality found in patients with type II diabetes with microalbuminuria is primarily due to cardiovascular disease.
14 In a recent epidemiological study in elderly patients, blood pressure was not increased in patients with newly diagnosed diabetes, but a 7% elevation of systolic pressure and no increase in diastolic pressure were noted in patients known to have diabetes. 21 Several studies demonstrated an apparent association between blood pressure level and rate of decline in renal function (Table 9) .
2 -4 -5 -"• 22 -" It is obvious that blood pressure elevation is only one factor in the complex pattern of pathogenetic mechanisms. In most studies so far reported, GFR was clearly decreased when treatment was started. When renal function is already reduced, GFR will continue to decline (although the rate may vary considerably) with hyperfunction of the remaining glomeruli. This process is probably a common final pathway to a number of renal diseases and quite unspecific for diabetic nephropathy. It is unique that in the early phase of diabetes, hyperfiltration is seen, probably in most glomeruli, although the extent varies among patients. 13 Structural lesions are also present. Therefore this final destructive pathway may be more easily established in diabetic patients 16 ; however, a marked elevation of GFR is required. How hypertension is generated in these patients with clinically overt diabetic nephropathy is less clear, but some evidence suggests that mesangial expansion plays an important role. 18 High blood pressure was identified as an important factor in determining progression in many studies but not all. 26 This may be due to differences in the composition of the studies. No association between blood pressure and progression in diabetic nephropathy was found when patients were above age 40 years, 27 and probably an association is less clear when only patients with a rather narrow range of pressures are included. 5 It is important to underline that a high degree of linearity in the progression of nephropathy has been found in diabetic patients. This is specifically apparent in the report by Parving et al. 5 When all GFR data from •Creatinine clearance. tDifferent by definition. NM = not measured; s = significant difference; NS = no significant difference.
this carefully conducted prospective study were pooled, a striking linearity in progression was observed. Such a linearity cannot be expected when patients in different age groups, treated with various drugs or not treated, are evaluated in a retrospective manner with no specific study plan.
It is most likely that progression is slower in the incipient phase and early in overt diabetic nephropathy. The GFR starts to decline in the incipient phase 13 and it can be expected that the rate will be slow at first, then accelerate, and at last become linear. There are obvious reasons why linearity is not seen in all patients. The GFR may vary according to glycemic control, actual blood pressure level, and degree of hydration, as well as for unidentified reasons. Furthermore, the inherent inaccuracy in determining renal function should be considered; however, the marked linearity supports the concept that treatment can be evaluated when comparing long-term fall rate of GFR both without intervention and during therapy.
